Resilient Medical Growth and a Historically Low Valuation Create a Compelling Opportunity
View all Materialise reports and link to our research disclaimer.
Company Overview
Materialise MTLS 0.00%↑ is a leading provider of additive manufacturing and medical software, and 3D printing services. Their Software segment offers software that enhance the functionality of 3D printers and manage enterprise wide 3D printing workflows. The Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. The Manufacturing segment produces 3D printed prototypes and production parts for several industrial and consumer industries. Materialise is traded on the Nasdaq exchange under the ticker MTLS, and is headquartered in Belgium.
Below we present our updated core investment thesis on Materialise, reflecting our latest analysis of the company's growth trajectory and overall profitability outlook. We include access to our downloadable 5-year financial model and our latest price target assessment.